Announcement of the launch of SCIO Capital’s Partners Fund II, targeting European CLO equity where SCIO can take a key role in structuring the equity.
This website is directed only at persons in the United Kingdom and the European Economic Area that qualify as professional clients or eligible counterparties as defined by the Financial Conduct Authority. The information in this website is not intended for the use of and should not be relied on by any person who would qualify as a retail client. If you are uncertain about whether you qualify as a professional client or as an eligible counterparty, you should seek independent advice from your legal and financial advisers.
In the United States, this website is intended only for qualified purchasers as defined in Section 2(a)(51) of the U.S. Investment Company Act of 1940, as amended.
Persons resident in jurisdictions other than the UK or US should consult their professional advisers to determine whether there are any restrictions, any requirements for regulatory, governmental or other consent, or any other formalities to be observed to enable them to invest in our investment products.
The information on this website is provided for your general information only and does not constitute the giving of any investment advice or an offer to sell or the solicitation of an offer to buy any product or service by us and must not be relied upon at any time or in any circumstances by anyone entering this website in connection with any investment decision. The information on this website does not constitute a financial promotion for the purposes of the Financial Services and Markets Act 2000 and rules and guidance issued from time to time by the Financial Conduct Authority. The information and material on this website is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities or any service in any jurisdiction.
Any decision to purchase interests in any Fund described on this website must be based solely upon the information contained in the prospectus of the relevant Fund and subscriptions will only be received and shares issued on the basis of the current prospectus of the relevant Fund; you are referred to this document if further information is required.
No information provided on this website in relation to any product or service should be construed as investment or other advice to you on the suitability or otherwise of that product or service for any person, such suitability depending on all the circumstances of the person concerned and all persons should consult with their own financial and other appropriate professional advisers as to all matters concerning any potential investment or any interest in any investment.
By clicking the ‘ACCEPT’ button below, entering this website and continuing to use it, you represent and confirm that you are a professional client or eligible counterparty as defined by the Financial Conduct Authority, or in the US are a qualified purchaser as defined in Section 2(a)(51) of the U.S. Investment Company Act of 1940, as amended , or that otherwise there are no restrictions in place that prevent you from accessing this website and/or considering any investment products or services detailed therein, and that you agree to be fully bound by the terms and conditions of this Legal Notice and our full terms and conditions of use of our website which you should read before using this website. Please note that you may be required to provide documentary evidence in support of your identity and categorisation as a professional client or eligible counterparty or qualified purchaser where we are considering making a financial promotion to you or we are considering entering into a contract with you as an investor or you are considering making an investment.
SCIO Capital LLP is authorised and regulated by the Financial Conduct Authority.
References to ‘we’, ‘us’, ‘our’, ‘firm’, ‘SCIO’ or ‘SCIO Capital’ mean SCIO Capital LLP. SCIO®, SCIO Capital® and the SCIO logo® are registered trade-marks of SCIO CAPITAL LLP® in the United Kingdom. All rights reserved.